GSK-3: tricks of the trade for a multi-tasking kinase
By B. Doble, J. Woodgett. Journal of Cell Science, 2003
2,180 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/7ee8f1753ec894642235373ba64c8709db7b2485
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity (2016, neutral): “It was later shown to be a key component of the Wnt signalling pathway, which plays important roles in embryonic development and tumorigenesis 17,18 .”
- Serotonin modulates circadian entrainment in Drosophila. (2005, background): “GSK3β activity is regulated (inhibited) by phosphorylation of an N-terminal pseudosubstrate site (ser9) and thus can be monitored through the use of phosphospecific antibodies directed to this modified form (Doble and Woodgett, 2003; Papadopoulou et al., 2004).”
- The activation of Akt/PKB signaling pathway and cell survival (2005, background): “GSK3 is also involved in many other signaling pathways, including the β-catenin-TCF/LEF transcriptional pathway [98].”
- Functional redundancy of GSK-3α and GSK-3β in wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines (2007, background): “However, it has since been shown to play far broader roles in many cellular processes (Doble and Woodgett, 2003).”
- Protein kinase cascades in the regulation of cardiac hypertrophy. (2005, background): “both of these branches can also be regulated by stress-activated, Gq-dependent mechanisms that are independent of Akt (Figure 1) (32, 33), which likely explains in part the ability of the Akt1–/– mouse heart to hypertrophy in response to pathologic stress.”
- LTP inhibits LTD in the hippocampus via regulation of GSK3beta. (2007, positive): “Other upstream signalling pathways can also regulate GSK3β and, in the case of Wnt signalling, this involves direct protein:protein interactions with GBP/FRAT1 (Doble and Woodgett, 2003).”
- WNT and β-catenin signalling: diseases and therapies (2004, background): “GSK3, as its name (glycogen synthase kinase) implies, is regulated by other pathway”
- Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. (2016, background): “Plasma contains many types of enzymes (such as glycogen synthase) [17] that enable the breakdown and metabolism of various biomolecules (such as cholesterol, and bilirubin) in bile ducts.”